Skip to content

Pharmacovigilance services

Pharmacovigilance, or drug safety, is crucial to understanding a drug, biologic or combination product’s risk-benefit profile and protecting the welfare of patients by systematically detecting and assessing adverse events. 

Pharmacovigilance servicestwo-women-notes

We offer pharmacovigilance services including SUSAR reporting, medical monitoring, and coding of adverse events, medical history and prior/concomitant medications.

Monitoring drug safety

Pharmacovigilance is the study of detecting, assessing, and understanding adverse effects to monitor the safety of medicines. Drug safety monitoring is performed during clinical studies and we can support you with medical monitoring, SAE reporting, and SUSAR reporting to the regulatory authorities. In addition, pharmacovigilance is an important part of the product’s entire lifecycle and we also support sponsors with routine safety reporting to the authorities (DSURs/PSURs).

Medical monitors work closely with the sponsor and sites to perform qualified medical reviews of, for example, SAEs/SUSARs as well as providing general oversight and immediate support when safety issues arise. We understand that when it comes to safety, what we do is as important as how we do it, and in addition to regulatory compliance, we believe that clear communication, efficient reporting procedures, and seamless collaboration are essential for success.

Pharmacovigilance services also include:

  • Safety reporting including SUSARs, DSURs/PSURs, and patient safety narratives
  • Medical monitoring including medical review of clinical data and consultation with medical monitors
  • Coding of adverse events, medical history and prior/concomitant medications

Contact us for more information

Meeri Säily
Meeri Säily
Sales Director, Consulting and Clinical Trials

Leave a contact request

Latest news

aurevia

Introducing Aurevia

Aurevia merges Labquality, Artimed, Kasve & Prisma CRO, uniting EQAS, clinical research & QA services. Offices in...

New EQA schemes for 2025

Introducing our new EQA schemes for 2025!
World Patient Safety Day is celebrated on 17 September

Patient Safety: The Cornerstone of Healthcare

Learn how Labquality supports patient safety in healthcare through external quality assessments, clinical trials,...

EQA Program 2025

The 2025 EQA program has now been published!

Does your device require a clinical investigation?

Clinical investigations are mandatory for certain medical devices in the EU. But how to know if your product requires a...